The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Diclac Retard 100 mg Prolonged-release Tablets



Rowex LtdPA0711/009/006

Main Information

Trade NameDiclac Retard 100 mg Prolonged-release Tablets
Active SubstancesDICLOFENAC SODIUM
Dosage FormProlonged-release tablet
Licence HolderRowex Ltd
Licence NumberPA0711/009/006

Group Information

ATC CodeM01AB Acetic acid derivatives and related substances
M01AB05 diclofenac

Status

License statusAuthorised
Licence Issued05/03/1992
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0056-024-024
Interchangeable List DocumentPDF of Interchangeable List
« Back